Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2008 | 10-2007 | 12-2006 | 10-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,100 | 123,500 | N/A | 93,300 | N/A |
| Depreciation Amortization | 86,600 | 69,500 | N/A | 68,800 | N/A |
| Income taxes - deferred | 1,500 | -6,200 | N/A | -46,900 | N/A |
| Accounts receivable | 4,900 | -15,000 | N/A | 19,500 | N/A |
| Accounts payable and accrued liabilities | -12,700 | 1,000 | N/A | 16,600 | N/A |
| Other Working Capital | -26,100 | -29,700 | N/A | -50,300 | N/A |
| Other Operating Activity | 161,500 | -1,300 | 0 | -14,100 | 0 |
| Operating Cash Flow | $175,600 | $141,800 | $N/A | $86,900 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42,100 | -29,200 | N/A | -31,800 | N/A |
| Net Acquisitions | -198,300 | -1,000 | N/A | N/A | N/A |
| Purchase Of Investment | -9,800 | -1,010,200 | N/A | -577,100 | N/A |
| Sale Of Investment | 39,700 | 1,263,200 | N/A | 519,000 | N/A |
| Other Investing Activity | -3,400 | -900 | 0 | 22,900 | 0 |
| Investing Cash Flow | $-213,900 | $221,900 | $N/A | $-67,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 451,600 | N/A | N/A | N/A | N/A |
| Debt Repayment | -221,100 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 500 | 4,800 | N/A | 9,600 | N/A |
| Common Stock Repurchased | -56,500 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -10,700 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $163,800 | $4,800 | $N/A | $9,600 | $N/A |
| Exchange Rate Effect | -14,300 | 9,500 | N/A | 4,500 | N/A |
| Beginning Cash Position | 520,200 | 142,200 | N/A | 108,200 | N/A |
| End Cash Position | 631,400 | 520,200 | N/A | 142,200 | N/A |
| Net Cash Flow | $111,200 | $378,000 | $N/A | $34,000 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 175,600 | 141,800 | N/A | 86,900 | N/A |
| Capital Expenditure | -42,400 | -30,400 | N/A | -33,000 | N/A |
| Free Cash Flow | 133,200 | 111,400 | 0 | 53,900 | 0 |